Advantages, disadvantages, availability, and applications of novel technologies in CHD
Technology . | Advantages . | Disadvantages . | Availability . | Applications in CHD . |
---|---|---|---|---|
4D Flow |
| Can be time-consuming | Widely available | Can be applied to every patient with CHD for blood flow assessment (e.g. stroke volumes, regurgitant volumes, Qp/Qs) |
Mapping techniques |
|
| Widely available | Can be applied to every patient with CHD with suspicion of diffuse myocardial changes |
3D cine |
|
| Not everywhere available | Can be applied to every patient with CHD |
Diffusion tensor imaging |
|
| Not everywhere available | Not ready for routine clinical use |
Lymphatic imaging |
|
| Widely available | Especially used in single-ventricle patients on the Fontan pathway or with an established Fontan circulation |
Foetal MRI |
|
|
| Can be used to assess foetal cardiovascular anatomy and haemodynamics. Assessment of foetal interventions might be possible. |
Stress MRI |
|
|
| In patients with suspected coronary artery pathology in the setting of CHD or acquired paediatric heart disease (e.g. transposition of the great arteries, Kawasaki syndrome) |
Catheter MRI |
|
| Not everywhere available | Pulmonary vascular resistance measurements are well approved in patients with a Fontan circulation or with pulmonary hypertension |
Computational fluid dynamics |
|
| Not everywhere available | CFD has been mainly applied in assessing Fontan connections and in patients with aortic diseases. Other applications are possible. |
Deep learning |
|
| Not everywhere available | Segmentation of 2D and 3D image data sets (e. g. volumetric measurements) |
Strain imaging |
|
| Widely available | Can be applied to every patient with CHD, especially in the context of ventricular dysfunction. |
3D printing |
|
| Not everywhere available |
|
Virtual/augmented reality |
|
| Not everywhere available |
|
Technology . | Advantages . | Disadvantages . | Availability . | Applications in CHD . |
---|---|---|---|---|
4D Flow |
| Can be time-consuming | Widely available | Can be applied to every patient with CHD for blood flow assessment (e.g. stroke volumes, regurgitant volumes, Qp/Qs) |
Mapping techniques |
|
| Widely available | Can be applied to every patient with CHD with suspicion of diffuse myocardial changes |
3D cine |
|
| Not everywhere available | Can be applied to every patient with CHD |
Diffusion tensor imaging |
|
| Not everywhere available | Not ready for routine clinical use |
Lymphatic imaging |
|
| Widely available | Especially used in single-ventricle patients on the Fontan pathway or with an established Fontan circulation |
Foetal MRI |
|
|
| Can be used to assess foetal cardiovascular anatomy and haemodynamics. Assessment of foetal interventions might be possible. |
Stress MRI |
|
|
| In patients with suspected coronary artery pathology in the setting of CHD or acquired paediatric heart disease (e.g. transposition of the great arteries, Kawasaki syndrome) |
Catheter MRI |
|
| Not everywhere available | Pulmonary vascular resistance measurements are well approved in patients with a Fontan circulation or with pulmonary hypertension |
Computational fluid dynamics |
|
| Not everywhere available | CFD has been mainly applied in assessing Fontan connections and in patients with aortic diseases. Other applications are possible. |
Deep learning |
|
| Not everywhere available | Segmentation of 2D and 3D image data sets (e. g. volumetric measurements) |
Strain imaging |
|
| Widely available | Can be applied to every patient with CHD, especially in the context of ventricular dysfunction. |
3D printing |
|
| Not everywhere available |
|
Virtual/augmented reality |
|
| Not everywhere available |
|
CHD, congenital heart disease; CFD, computational fluid dynamics; ECV, extracellular volume; MR, magnetic resonance; MRI, magnetic resonance imaging; 3D, three-dimensional; 2D, two-dimensional.
Advantages, disadvantages, availability, and applications of novel technologies in CHD
Technology . | Advantages . | Disadvantages . | Availability . | Applications in CHD . |
---|---|---|---|---|
4D Flow |
| Can be time-consuming | Widely available | Can be applied to every patient with CHD for blood flow assessment (e.g. stroke volumes, regurgitant volumes, Qp/Qs) |
Mapping techniques |
|
| Widely available | Can be applied to every patient with CHD with suspicion of diffuse myocardial changes |
3D cine |
|
| Not everywhere available | Can be applied to every patient with CHD |
Diffusion tensor imaging |
|
| Not everywhere available | Not ready for routine clinical use |
Lymphatic imaging |
|
| Widely available | Especially used in single-ventricle patients on the Fontan pathway or with an established Fontan circulation |
Foetal MRI |
|
|
| Can be used to assess foetal cardiovascular anatomy and haemodynamics. Assessment of foetal interventions might be possible. |
Stress MRI |
|
|
| In patients with suspected coronary artery pathology in the setting of CHD or acquired paediatric heart disease (e.g. transposition of the great arteries, Kawasaki syndrome) |
Catheter MRI |
|
| Not everywhere available | Pulmonary vascular resistance measurements are well approved in patients with a Fontan circulation or with pulmonary hypertension |
Computational fluid dynamics |
|
| Not everywhere available | CFD has been mainly applied in assessing Fontan connections and in patients with aortic diseases. Other applications are possible. |
Deep learning |
|
| Not everywhere available | Segmentation of 2D and 3D image data sets (e. g. volumetric measurements) |
Strain imaging |
|
| Widely available | Can be applied to every patient with CHD, especially in the context of ventricular dysfunction. |
3D printing |
|
| Not everywhere available |
|
Virtual/augmented reality |
|
| Not everywhere available |
|
Technology . | Advantages . | Disadvantages . | Availability . | Applications in CHD . |
---|---|---|---|---|
4D Flow |
| Can be time-consuming | Widely available | Can be applied to every patient with CHD for blood flow assessment (e.g. stroke volumes, regurgitant volumes, Qp/Qs) |
Mapping techniques |
|
| Widely available | Can be applied to every patient with CHD with suspicion of diffuse myocardial changes |
3D cine |
|
| Not everywhere available | Can be applied to every patient with CHD |
Diffusion tensor imaging |
|
| Not everywhere available | Not ready for routine clinical use |
Lymphatic imaging |
|
| Widely available | Especially used in single-ventricle patients on the Fontan pathway or with an established Fontan circulation |
Foetal MRI |
|
|
| Can be used to assess foetal cardiovascular anatomy and haemodynamics. Assessment of foetal interventions might be possible. |
Stress MRI |
|
|
| In patients with suspected coronary artery pathology in the setting of CHD or acquired paediatric heart disease (e.g. transposition of the great arteries, Kawasaki syndrome) |
Catheter MRI |
|
| Not everywhere available | Pulmonary vascular resistance measurements are well approved in patients with a Fontan circulation or with pulmonary hypertension |
Computational fluid dynamics |
|
| Not everywhere available | CFD has been mainly applied in assessing Fontan connections and in patients with aortic diseases. Other applications are possible. |
Deep learning |
|
| Not everywhere available | Segmentation of 2D and 3D image data sets (e. g. volumetric measurements) |
Strain imaging |
|
| Widely available | Can be applied to every patient with CHD, especially in the context of ventricular dysfunction. |
3D printing |
|
| Not everywhere available |
|
Virtual/augmented reality |
|
| Not everywhere available |
|
CHD, congenital heart disease; CFD, computational fluid dynamics; ECV, extracellular volume; MR, magnetic resonance; MRI, magnetic resonance imaging; 3D, three-dimensional; 2D, two-dimensional.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.